Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Exclusion Criteria

• •1. Ischemic stroke occurred within 7 days before enrolment
• •2. Tandem extracranial or intracranial stenosis (70%-99%) or occlusion that is proximal or distal to the target intracranial lesion (NOTE: an exception is allowed if stenosis or occlusion involves a single vertebral artery proximal to a symptomatic basilar artery stenosis and the contralateral vertebral artery is supplying the basilar artery)
• •3. Bilateral intracranial vertebral artery stenosis of 70%-99% and uncertainty about which artery is symptomatic (NOTE: an exception is that if bilateral vertebral arteries with 70%-99% stenosis but unequal in size, the dominant side is considered as symptomatic)
• •4. Unilateral vertebral artery stenosis of 70%-99% with normal contralateral vertebral artery
• •5. Stroke caused by perforating artery occlusion
• •6. CT angiographic evidence of severe calcification at target lesion
• •7. Any history of brain parenchymal or subarachnoid, subdural or extradural haemorrhage in the past 6 weeks
• •8. Intracranial artery stenosis caused by non-atherosclerotic lesions, including: arterial dissection, Moyamoya disease, vasculitis disease, herpes zoster, varicella-zoster or other viral vascular diseases, neurosyphilis, any other intracranial infections, any intracranial stenosis related to cerebrospinal fluid cells, radiation-induced vascular disease, fibromuscular dysplasia, sickle cell disease, neurofibromatosis, central nervous system benign vascular disease, postpartum vascular disease, suspected vasospasm, suspicious embolism recanalization, etc
• •9. History of stenting of an intracranial artery
• •10. Presence of any unequivocal cardiac source of embolism
• •11. Combined with intracranial tumor, aneurysm or intracranial arteriovenous malformation
• •12. Cannot tolerate dual antiplatelet therapy
• •13. Contraindications to heparin, rapamycin, contrast and local or general anesthesia
• •14. Hemoglobin\<100g/L, platelet count \<100×109/L
• •15. Severe hepatic and renal dysfunction
• •16. INR\>1.5 or there are uncorrectable factors leading to bleeding
• •17. Major surgery within the past 30 days or planned within 90 days
• •18. Renal artery, iliac artery, and coronary artery requiring simultaneous intervention
• •19. Life expectancy \<1 year
• •20. Pregnant or lactating women
• •21. Cannot complete the follow-up due to cognitive, emotional or mental illness
• •22. Other situations that are not suitable for enrolment according to the judgement of the investigator
• •23. Enrolment in another study that would conflict with the current study